Want to join the conversation?
Rick Wise of Stifel, Nicolaus asks about procedure growth. CFO Marshall Mohr said the mature procedure contributions that $ISRG saw in 1H16 will not be as strong in 2H16. He added that the company continues to expect and will continue to drive growth in US general surgery, and in its overseas markets in urology and early stage emerging procedures.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!